Chronic Kidney Disease in Type 2 Diabetes research hub

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

This study looks at how a drug called semaglutide affects body fat and the liver in people with type 2 diabetes and kidney disease. It aims to understand how this medication helps improve health by looking closely at fat tissue.